TABLE 2.
Clinical Trials Using Nanoparticles
Type | Size (nm) | Agent and modality | Motivation | Indication | Trial |
Sulfur colloid | <220 | 99mTc, SPECT | Map lymph nodes during rectal surgery | Colon cancer | NCT02112240 |
Sulfur colloid | <220 | 99mTc, SPECT | Raise pH of contrast agent to minimize pain | Cancer | NCT01660412 |
Sulfur colloid | <220 | 99mTc, SPECT | Map lymph nodes during rectal surgery | Head and throat cancer | NCT00012168 |
Gold | 150 | Nanoshell, photothermal | Increase local heating better than by laser alone | Head and neck cancer | NCT00848042 |
Silica | 3–10 | 124I and Cy5, PET and optical | Define sentinel lymph nodes | Melanoma | NCT01266096 |
Iron oxide | 17–30 | Ferumoxytol, MRI | Monitor response to bevacizumab therapy | Glioma | NCT00769093 |
Iron oxide | 17–30 | Ferumoxytol, MRI | Localize lymph node metastases | Pancreatic cancer | NCT00920023 |
Iron oxide | 80–150 | Ferumoxide, MRI | Identify presence of implanted stem cells | Inflammation | NCT01169935 |
Iron oxide | 17–30 | Ferumoxytol, MRI | Detect recent myocardial infarction | Myocardial infarction | NCT01995799 |